Positive results from a study of Winrevair could help the drugmaker achieve sales growth past top-seller Keytruda’s upcoming patent expirations this decade. Published Nov. 25, 2024 Jonathan GardnerSenior Reporter Merck announced on Nov. 25, 2024, that its pulmonary arterial hypertension drug Winrevair succeeded in a clinical trial. Marko Georgiev / Stringer via Getty Images Dive Brief:...
Tag: <span>cardiovascular drugs</span>
Post
Certain combinations of cardiovascular drugs may reduce dementia risk
by Jenesse Miller, University of Southern California Specific combinations of statins and antihypertensives may also reduce risk for Alzheimer’s disease, according to a new USC study of nearly 700,000 Medicare beneficiaries. The findings suggest that treatments already in use for blood pressure and cholesterol control could reduce the number of people with Alzheimer’s and related dementias,...